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Abstract
Background: Dengue viral infections are known to pose a significant risk during travel to tropical regions, but it is
surprising to find dengue transmission in the hilly region of Nepal, which is over 1800mtr above sea level.
Case presentation: A 43-year-old Caucasian female traveler from France presented with fever and abdominal pain
following a diarrheal illness while visiting the central hilly region of Nepal. Over the course of 9 days, she developed
fever, body aches, and joint pain, with hemorrhagic manifestation. She was hospitalized in India and treated with
supportive care, with daily monitoring of her platelets. An assessment by enzyme-linked immunosorbent assay
showed that she was positive for dengue non-structural protein 1. Upon her return to France, dengue virus was
confirmed by reverse transcriptase-polymerase chain reaction.
Conclusion: The district where this dengue case was reported is in the hilly region of Nepal, neighboring the capital
city Kathmandu. To the best of our knowledge, there has previously been no dengue cases reported from the district.
This study is important because it aims to establish a potential region of dengue virus circulation not only in the
tropics, but also in the subtropics as well, which in Nepal may exceed elevations of 1800mtr. This recent case report
has raised alarm among concerned health personnel, researchers, and organizations that this infectious disease is now
on the way to becoming established in a temperate climate.
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Background
Dengue is a mosquito-borne flaviviral infection that is
endemic to the tropics and subtropics, affecting up to
100 million people per year [1]. The presentation of
dengue virus (DENV) infection can be asymptomatic or
manifest as a febrile illness; dengue fever. However,
subsets of patients may develop dengue hemorrhagic
fever, with complications such as gastrointestinal bleed-
ing and ecchymoses, which may result in the potentially
lethal form of the disease; dengue shock syndrome [2–
4]. Around the world there are four distinct dengue
virus serotypes (DENV 1–4) [5]. Interestingly, infection
with one serotype confers serotype-specific immunity to
the host; however, if subsequent infection occurs with a
different serotype, it can predispose the host to a grave
clinical outcome [6–8].
Nepal shares an open border with India, an endemic
region for DENV, thus is susceptible to an unprece-
dented flow of virus through infected patients crossing
the border. Regulatory checkpoints and quarantines are
not currently in place along the Nepali border. In 2013,
a Nepali team isolated and characterized DENV circulat-
ing in a part of the eastern Terai that had previously seen
cases of dengue in 2006 [9]. Comparing the data, Singh et
al. [10] reported that, in fact, there were two different
strains of DENV circulating in Nepal, raising the specter
of an alarming dengue situation in Nepal.
We report a case of DENV infection in a Caucasian
woman while she was traveling through the hilly region
of Nepal.
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Case presentation
A 43-year-old Caucasian female arrived in Kathmandu
from Paris, and the same day traveled to Kavre District,
in the inner hilly region (elevation: 1800mtr) of Nepal.
Nine days after arriving in the hilly region, she devel-
oped fever, body aches and joint pain. She also experi-
enced loose stools and vomiting along with hemorrhagic
manifestations such as facial flushing, petechiae and
edema. She was subsequently admitted to a hospital in
Goa, India, owing to health insurance requirements.
Upon examination, her blood pressure and other vital
signs were normal, without abdominal distension or
bleeding. Ultrasonography of her abdomen and pelvis
showed borderline splenomegaly (12cm). An enzyme-
linked immunosorbent assay was positive for dengue
non-structural protein 1, although tests for immunoglob-
ulins G and M were negative. She was given supportive
care, including intravenous fluids. Daily monitoring of her
platelet count revealed values as low as 37,000/mm3
(Table 1). She was discharged from the hospital in Goa
after 5 days, and returned to Paris, where she was hospi-
talized briefly and discharged. Dengue virus was con-
firmed by reverse transcriptase-polymerase chain reaction
in Paris.
Discussion
The first case of DENV2 infection in Nepal was reported
in 2004 in a Japanese traveler [11]. Subsequently, con-
firmed cases were reported from nine districts in the
lowland Terai region of Nepal in 2006, and all four
DENV serotypes were found to be co-circulating that
year [9]. Over the years, the Terai belt, located south of
the Himalayan foothills, has become an established dengue
region. However, only limited data have been generated
about DENV infection and disease in Nepal. Two major
outbreaks have occurred in Nepal: one in 2010, dominated
by DENV1, and the other in 2013, dominated by
DENV2 [10, 12]. Dengue was reported in the highlands
for the first time during the 2010 outbreak [12]. The
2013 outbreak also affected the highlands, including
Kathmandu, though it was predominantly confined to
Chitwan, Rupandehi, Parsa, and Dhanusa [10]. The shift
of the viral disease from the subtropical Terai belt to
the temperate hill region of Nepal is relevant to medical
science because the disease could easily spread all over
the world in the future, irrespective of climate [13]. The
village to which the patient had traveled is at an eleva-
tion of 1800mtr. It is becoming apparent that DENV is
adapting to temperate climates as well. This may be
because of temperature change due to global warming,
the resistance of mosquitoes to drugs, or other factors,
all of which may have contributed to the increase in
dengue fever cases around the world in recent years.
Reports of dengue among travelers worldwide have been
increasing, but high-quality data on incidence are lacking.
The increase in international travel to dengue-endemic re-
gions, with the associated risk of travel-acquired dengue,
poses a serious concern [14]. The shift in temperature
around the world has enabled DENV to thrive in colder
regions where it was previously not reported. To look for
the causes, the mosquito vector Aedes spp. and mutations
in the virus should be the foci of future research. A.
aegypti was first reported in Kathmandu in 2010 and the
vectors may have now established populations up in the
mountains [12]. Serotype and genotype shifts have been
reported based on sequencing of specific viral regions [15].
In-depth molecular study of the virus found in the hill re-
gion of Nepal might give insights into the climatic shift of
dengue disease. Therefore, the authors strongly recom-
mend active surveillance and identification of mosquitoes
along with whole genome sequencing of the virus for
greater awareness as well as knowledge of dengue fever
and dengue hemorrhagic fever transmission.
Conclusion
This is the second report of DENV infection in a
foreigner travelling in Nepal, after the case in a Japa-
nese traveler reported in 2004. Although initially it
was thought that only the Terai belt of Nepal was
endemic for dengue, a number of dengue cases are
also being reported from the hill region. The Gov-
ernment of Nepal should take the initiative to elim-
inate adult mosquitoes, as well as larvae and eggs, to
prevent further transmission of arboviruses in the
hill region of Nepal, which is one of the most at-
tractive touristic sites in Nepal.
Table 1 Laboratory parameters of dengue case
Test Result
Hemoglobin 13.6 g/dL
Packed cell volume 39.1 L/L
Platelets 37,000/mm3
Total bilirubin 0.9 mg/dL
Direct bilirubin 0.4 mg/dL
Serum glutamic oxaloacetic transaminase 93 IU/L
Serum glutamic-pyruvic transaminase 54 IU/L
Alkaline phosphatase 53 IU/L
Total proteins 7.7 g/dL
Albumin 4 g/dL
Globulin 3.7 g/dL
Albumin to globulin Ratio 1.08
Gamma-glutamyl transferase 45 IU/L
Dengue immunoglobulin G and M Negative
Dengue non-structural protein 1 antigen Positive
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